Home › Kleiner Perkins's Beth Seidenberg Says Immunotherapy Is Biotech Powerhouse
 

Keywords :   


Kleiner Perkins's Beth Seidenberg Says Immunotherapy Is Biotech Powerhouse

2015-03-24 05:50:52| Biotech - Topix.net

Investing in biotechnology is known to be tough, as startups often face years of development time, clinical trials and regulatory work before maturing to the point where they can offer returns for the investors. But Kleiner Perkins Caufield & Byers recently bucked that trend, reaping well over 10 times what it put into immunotherapy company Flexus Biosciences Inc. in less than a year and a half.

Tags: beth kleiner biotech powerhouse

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
05.11Shoppers warned over luxury advent calendar scams
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
05.11Teknos Poland Honored by Farby i Lakiery
05.11Xumo teams up with Target to offer Hisense Xumo TVs
05.11KT launches 8K AI-powered IPTV set-top box
05.11Tropical Storm Rafael Graphics
More »